Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Ruchi Gupta

THE TRUTH ABOUT: 1 strong buy biotech stock with 132 upside potential - The Untold Story

Absci Corp (ABSI) is a biotech company that produces protein development technologies. As a data-first generative artificial intelligence (AI) drug creator, ABSI uses an integrated drug development platform that builds on traditional biological drug discovery with the help of AI to optimize multiple characteristics of the drug that may prove to be important towards development and effect of the drug. 

Founded in 2011, the company operates out of Vancouver, Washington. Valued at a market cap of $408 million, the small-cap biotech is a component of the benchmark Russell 2000 Index (RUT). 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.